SUMMARY Severe osteomalacia (confirmed by the examination of thin undecalcified bone biopsy sections) associated with hypophosphataemia developed in a 60 year old woman. A skeletal x-ray survey showed a lytic lesion in the right proximal femur, and this was curetted, showing a vascular tumour. The patient's symptoms improved almost immediately and serum phosphate concentrations returned to normal. Some time later the syndrome and the tumour recurred. The tumour was excised, and again the patient improved. Morphological examination of the tumour showed a lesion which closely resembled haemangiopericytoma. Review of published reports confirmed that most reported cases have been associated with "vascular" mesenchymal tumours both in intraosseous and extraosseous sites.
Throughout the world the most common cause of the osteomalacia and rickets syndrome is vitamin D deficiency due to dietary deprivation. There are, however, several other causes of the syndrome, which, although not necessarily common, are important: their recognition may lead to effective treatment; and an understanding of their pathogenetic mechanisms may give important insights into the processes of bone mineralisation. One such example is provided by the phenomenon of oncogenic osteomalacia. This seems to be a genuinely rare syndrome, in which osteomalacia is seen in association with a mesenchymal tumour (either intraosseous or extraosseous), and the osteomalacia heals when the tumour is removed. Concomitant hypophosphataemia commonly occurs.
Recently we had the opportunity of studying tumour and bone tissue from such a case and used light microscopical, ultrastructural, and undecalcified histological techniques to characterise the morphological features of the syndrome, which are detailed in this paper.
Case report
A 60 year old woman presented with increasing pain in both thighs associated with weakness, over two years. Latterly she developed increasing pain in both knees and ankles. She had been confined to a wheel Accepted for publication 13 August 1986 chair for 18 months. There was no history of excess antacid ingestion or nutritional deficiency. There was no family history of bone disease.
Clinical examination showed a severe weakness in all pelvic girdle muscles. There was mild weakness of the shoulder girdle muscles. All lower limb movements were limited by pain. There was no wasting, diminution of reflexes, or impairment of sensation.
Serum calcium concentration was at 2-24mmol/l (normal range 2 20-260) but serum phosphate con--centration at 0-40inmol/l (normal rafnge 0-80-1-30) and that of serum 25 hydroxycholecalcified at 36 IU/I (normal range 40-160) were both low. Urinary calcium and phosphate concentrations were normal. The serum alkaline phosphatase activity (1326 IU/l, normal range 0-110) and the serum parathormone activity (7-8 IU/l, normal range 2-0-6-0) were raised. Continuing investigations showed a persistently low serum phosphate concentration coupled with normal serum calcium concentrations, high normal urinary calcium excretion, and low normal urinary phosphate excretion. This suggested a low tubular phosphate reabsorption. There was a low oral calcium absorption and a very high urinary hydroxyproline:creatinine ratio.
Oncogenic hypophosphataemic osteomalacia was presumptively diagnosed. A skeletal x-ray survey showed a lytic lesion in the right upper femur (fig 1) . An operation was performed at which the femoral lesion was curetted, a bone biopsy was taken from the left anterior iliac crest for undecalcified histological study, and a muscle biopsy as taken from the right quadriceps femoris muscle. Postoperatively her serum phosphate concentrations began to rise, urinary excretion fell, and the calcium absorption increased. She became mobilised and was able to walk. Her further improvement was complicated by pulmonary embolism for which she was successfully treated.
Nine months later her serum phosphate concentrations began to fall again and x-ray of the right upper femur showed a recrudescence of the lytic lesion. This area was excised en bloc ( fig 2) . After operation the serum phosphate concentration again returned to normal and she remains well at the time of writing.
Pathological findings
The bone biopsy specimen from the left iliac crest was fixed in buffered formalin containing a 1% solution of tetracycline for 48 hours.1 Multiple, thin (7 10) . These were concentrated beneath the plasma membrane and many seemed to be fused with the membrane. In places there were thin dense areas beneath the plasma membrane, especially in the cell processes. Junctional complexes were not observed, although in places plasma membranes were closely apposed.
Discussion
Undecalcified bone histology showed that the patient had a severe osteomalacia, due to hypophosphataemia. The association with an intraosseous tumour whose excision improved the biochemical and clinical abnormalities of the case indicates that this was an example of the oncogenic hypophosphataemic osteomalacia syndrome. The essential feature is that either an intraosseous or extraosseous tumour exerts an influence whereby serum, and, presumably, extracellular fluid phosphate, is depleted. This results in diminished calcification either at the calcification front in adult bone or in hypertrophic cartilage in the epiphyseal plate, thereby causing either osteomalacia or rickets depending on the age of the subject.
Fig 6 Reticulin pattern ofexcision specimen. x 100. That oncogenic hypophosphataemic osteomalacia is an unusual syndrome is illustrated by the fact that only 22 cases have been described. These comprise 12 males and 10 females with a mean age of 37 years (range 9-58). The average duration of symptoms is known from 12 cases and is an astonishingly long 5-28 years (range 0O6-17). Many of the patients were severely incapacitated by their osteomalacia and associated myopathy, being wheelchair-bound or bedridden. Although some cases have been controlled symptomatically by high doses of phosphate or vitamin D, or both, most have been successfully treated by identification of the associated tumour and its ablation. Failure to recognise the syndrome and the associated tumour was largely responsible for the long average duration of symptoms. The strong and immediate response to removal of the tumour emphasises the importance of accurate diagnosis.
In all the cases reported there has been biochemical or radiological evidence, or both, of osteomalacia, but only in six has this been confirmed by undecalcified bone histology. All cases had hypo- phosphataemia and 18 had hyperphosphaturia. Serum calcium concentrations were measured in 14 instances and were uniformly normal. Glycouria was observed in three cases and a low serum I-a-25-dihydroxycholecalciferol concentration noted in one. Our patient had normal serum calcium concentrations but persistently low serum phosphate values. There was a low normal phosphate excretion, indicating a low tubular phosphate reabsorption. In addition there was a low serum 25-hydroxycholecalciferol concentration.
It is evidently important to consider the sites and nature of the associated tumours. These were either extraosseous or intraosseous in location. Table 2 shows the location of the extraosseous lesions and Evans and Azzopardi stated that they performed ultrastructural studies in their case but did not give details. Linovitz et al" reported that their ultrastructural study showed a variegated pattern with vascular spaces, endothelial buds, rare smooth muscle cells and pericytes, together with less well differentiated cells. Specifically they could see no features of a hormone secreting tumour. In our case there were spindle cells with numerous processes, a discontinuous external lamina, and an amorphous non-fibrillar stroma. Subplasmalemmal densities McClure, Smith group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from were observed, but these could not be resolved into filaments. Although there has been some variation in the described ultrastructural features of reported cases of haemangiopericytoma,12 the features noted in the present case were entirely consistent with that diagnosis.
A distinctive feature of our case was the presence of large cytoplasmic vesicles surrounded by thick membrane and concentrated close to the plasmalemma. These vesicles were larger than conventional pinocytotic vesicles and have not been noted in previous reports of the ultrastructural features of haemangiopericytomas (most of which have been soft tissue lesions). It is tempting to postulate, but impossible to prove, that these might have represented an exocytotic (perhaps secretory) mechanism.
This then leads to a consideration of the way in which these associated tumours might be related to hypophosphataemic osteomalacia. The speculation has been that the tumours elaborate a peptide with an effect on the renal transport of phosphate.13 It has been further speculated that the hypothetical substance might be like parathormone-but lacking an action on bone cells. It might activate adenyl cyclase of the proximal convoluted tubule, thus impairing phosphate reabsorption. Against this Drezner and Feinglos`4 found a deficiency of l-a, 25 -dihydroxyvitamin D3 in their patient, which, when given, was followed by resolution of the clinical and biochemical abnormalities. Excision of the tumour allowed treatment to be discontinued. Their hypothesis therefore was that these tumours produce a substance which inhibits 25-hydroxycholecalciferol-1-hydroxylase activity, causing a decrease in the synthesis of 1, 25-dihydroxy vitamin D3, the deficiency of which is thought to cause renal phosphate wasting and the sequence of events leading to osteomalacia and myopathy.
These are as yet hypotheses as few of these interesting lesions have been studied in detail. Despite the absolute rarity of the syndrome it is of true clinical importance, because its recognition has profound implications for early and successful treatment.
